Trials / Active Not Recruiting
Active Not RecruitingNCT05763940
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
Efficacy of OmegaBoost to Increase Omega-3 Levels Particularly Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Healthy Individuals as Compared to the Leading Omega-3 Softgel and the Leading Omega-3 Gummy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Western University of Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine increases in the Omega Index test indicating optimal Omega-3s particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels for overall systemic benefits including healthy cardiovascular health and cholesterol levels as shown in the OmegaIndex (OmegaQuant) research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | OmegaBoost | An ultra-pure omega-3 fish oil supplement with no fishy aftertaste and no fish burps. 10x more omega-3 from fish oil than the leading omega-3 gummies. Gel bites have better absorption than ordinary, hard-to-swallow fish oil pills. |
| DIETARY_SUPPLEMENT | Nature Made (soft gel) | A commercially-available omega-3 soft gel formula |
| DIETARY_SUPPLEMENT | Nature Made (gummy) | A commercially-available omega-3 formula in gummy form |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2024-05-25
- Completion
- 2024-06-25
- First posted
- 2023-03-10
- Last updated
- 2024-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05763940. Inclusion in this directory is not an endorsement.